These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29589544)

  • 1. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
    Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
    Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.
    Braff MH; Hawkins MA; Di Nardo A; Lopez-Garcia B; Howell MD; Wong C; Lin K; Streib JE; Dorschner R; Leung DY; Gallo RL
    J Immunol; 2005 Apr; 174(7):4271-8. PubMed ID: 15778390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique features of human cathelicidin LL-37.
    Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
    Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LL-37 domain: A clue to cathelicidin immunomodulatory response?
    Leite ML; Duque HM; Rodrigues GR; da Cunha NB; Franco OL
    Peptides; 2023 Jul; 165():171011. PubMed ID: 37068711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37.
    Wang G; Narayana JL; Mishra B; Zhang Y; Wang F; Wang C; Zarena D; Lushnikova T; Wang X
    Adv Exp Med Biol; 2019; 1117():215-240. PubMed ID: 30980360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives for clinical use of engineered human host defense antimicrobial peptides.
    Pachón-Ibáñez ME; Smani Y; Pachón J; Sánchez-Céspedes J
    FEMS Microbiol Rev; 2017 May; 41(3):323-342. PubMed ID: 28521337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antimicrobial peptides: defensins, cathelicidins and histatins.
    De Smet K; Contreras R
    Biotechnol Lett; 2005 Sep; 27(18):1337-47. PubMed ID: 16215847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity.
    Yoshioka M; Fukuishi N; Kubo Y; Yamanobe H; Ohsaki K; Kawasoe Y; Murata M; Ishizumi A; Nishii Y; Matsui N; Akagi M
    Biol Pharm Bull; 2008 Feb; 31(2):212-6. PubMed ID: 18239275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LL-37, the only human member of the cathelicidin family of antimicrobial peptides.
    Dürr UH; Sudheendra US; Ramamoorthy A
    Biochim Biophys Acta; 2006 Sep; 1758(9):1408-25. PubMed ID: 16716248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cathelicidins in the innate host defenses of mammals.
    Zanetti M
    Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.
    Tjabringa GS; Aarbiou J; Ninaber DK; Drijfhout JW; Sørensen OE; Borregaard N; Rabe KF; Hiemstra PS
    J Immunol; 2003 Dec; 171(12):6690-6. PubMed ID: 14662872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from
    Chen Y; Cai S; Qiao X; Wu M; Guo Z; Wang R; Kuang YQ; Yu H; Wang Y
    Biochem J; 2017 Aug; 474(16):2861-2885. PubMed ID: 28798159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs.
    Jiang W; Sunkara LT; Zeng X; Deng Z; Myers SM; Zhang G
    Peptides; 2013 Dec; 50():129-38. PubMed ID: 24140860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity.
    Bryzek D; Golda A; Budziaszek J; Kowalczyk D; Wong A; Bielecka E; Shakamuri P; Svoboda P; Pohl J; Potempa J; Koziel J
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
    Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
    J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide.
    Bommineni YR; Pham GH; Sunkara LT; Achanta M; Zhang G
    Mol Immunol; 2014 May; 59(1):55-63. PubMed ID: 24491488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
    Tjabringa GS; Rabe KF; Hiemstra PS
    Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
    Zaiou M; Nizet V; Gallo RL
    J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial function of the human cathelicidin-18 peptide (LL-37) between theory and practice.
    Iacob SA; Iacob DG
    Protein Pept Lett; 2014; 21(12):1247-56. PubMed ID: 25101632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.